<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(9)</volume><submitter>Hayashi M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Optimal timing for treatment initiation in &lt;i>Mycobacterium avium&lt;/i> complex pulmonary disease (MAC-PD) remains unclear due to lack of established rules for predicting treatment response.&lt;h4>Methods&lt;/h4>A retrospective observational study was conducted to develop a prediction model for treatment failure at 2 Japanese university hospitals between 2012 and 2023. Participants were 135 patients with MAC-PD who received macrolides and ethambutol-containing regimens over 1 year. Treatment failure was defined as nonachievement culture conversion at 1 year. We selected model components as cavity (categorized by diameter) and bronchiectasis (categorized by modified Reiff score) on pretreatment computed tomography. Their combinations of each category were scored based on number o</pubmed_abstract><journal>Open forum infectious diseases</journal><pagination>ofaf565</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12465108</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Developing a Simple Scoring System on CT Findings for Predicting Treatment Failure in &amp;lt;i&amp;gt;Mycobacterium avium&amp;lt;/i&amp;gt; Complex Pulmonary Disease: The BCD (Bronchiectasis and Cavity Distribution) Score.</pubmed_title><pmcid>PMC12465108</pmcid><pubmed_authors>Matsukura S</pubmed_authors><pubmed_authors>Cho H</pubmed_authors><pubmed_authors>Yokoe T</pubmed_authors><pubmed_authors>Takishima H</pubmed_authors><pubmed_authors>Yamaguchi F</pubmed_authors><pubmed_authors>Hayashi M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Developing a Simple Scoring System on CT Findings for Predicting Treatment Failure in &amp;lt;i&amp;gt;Mycobacterium avium&amp;lt;/i&amp;gt; Complex Pulmonary Disease: The BCD (Bronchiectasis and Cavity Distribution) Score.</name><description>&lt;h4>Background&lt;/h4>Optimal timing for treatment initiation in &lt;i>Mycobacterium avium&lt;/i> complex pulmonary disease (MAC-PD) remains unclear due to lack of established rules for predicting treatment response.&lt;h4>Methods&lt;/h4>A retrospective observational study was conducted to develop a prediction model for treatment failure at 2 Japanese university hospitals between 2012 and 2023. Participants were 135 patients with MAC-PD who received macrolides and ethambutol-containing regimens over 1 year. Treatment failure was defined as nonachievement culture conversion at 1 year. We selected model components as cavity (categorized by diameter) and bronchiectasis (categorized by modified Reiff score) on pretreatment computed tomography. Their combinations of each category were scored based on number o</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T21:41:11.319Z</modification><creation>2026-05-02T03:08:14.24Z</creation></dates><accession>S-EPMC12465108</accession><cross_references><pubmed>41018706</pubmed><doi>10.1093/ofid/ofaf565</doi></cross_references></HashMap>